Observatoire des droits humains (anglais seulement)

Long COVID: with one in three patients back in hospital after three months, where are the treatments?

(Version anglaise seulement)

par Mark Toshner, Lecturer in Translational Respiratory Medicine, University of Cambridge

The pace of acute therapy and vaccine development for COVID have been dizzying. But even as we hope a route to bringing the pandemic under control is within sight, we’re now facing the possibility of another urgent public health emergency thanks to what’s known as long COVID, a group of symptoms that last long after the initial infection. With such a potential crisis looming, it is reasonable to ask what we are doing about it, and why treatments don’t appear to be forthcoming.

There are a few reasons why the long COVID story may pan out differently. Let’s take the first problem: long…

Lire l'article complet